|
|
|
|
|
|
|
| |
|
|
World-first Vaccine Candidate for Newborns to Help Combat Deadly Rotavirus
Listed On: Thursday, July 29, 2010
University of Melbourne
|
|
|
Australian researchers have begun clinical trials of a new vaccine to protect newborn infants against rotavirus, a life-threatening diarrhoeal disease that kills half a million children worldwide each year. ...Continue
|
|
|
Official URL: http://newsroom.melbourne.edu/news/n-326
|
|
|
Summary: Australian researchers have begun clinical trials of a new vaccine to protect newborn infants against rotavirus, a life-threatening diarrhoeal disease that kills half a million children worldwide each year. We aim to provide the RV3 vaccine at a lower cost than current vaccines available on the market. While we hope the vaccine will be available in Australia, our first priority will be the developing world, where 90 percent of rotavirus deaths occur. The vaccine will be made by Indonesian vaccine manufacturer BioFarma. "Our biggest challenge is getting vaccines to vulnerable children in a timely and cost-effective way," Professor Bines said. "If the trials are successful, our vaccine could offer a major boost for global efforts to reduce death and suffering from rotavirus in children worldwide." The trials follow the global recommendation by the World Health Organization last year that all children be vaccinated against rotavirus infection in an effort to reduce child mortality worldwide.
|
|
|
Email this article
|
|
|
|
|
|
